The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

Corrections

Published Online:https://doi.org/10.1176/ajp.139.3.387-b

In the January 1982 issue, the first six sentences of the third paragraph in the letter to the Editor "Dyskinesia and Unipolar Depression" by Paul S. Appelbaum, M.D., p. 140, should read as follows:

At the time of admission, Ms. A had been receiving maintenance therapy with imipramine, 75 mg/day. She displayed rhythmic movements of her pelvis, an antalgic gait in her right leg, facial grimacing, and dyskinetic movements of her hands. The physical findings remained unchanged during 2 weeks of treatment with imipramine, 100 mg/day, and acetophenazine, 20 mg/day. When Ms. A's mental status cleared after adjustment of her tricyclic dosage to 25 mg/day of imipramine, the neurologic findings, including the limp, disappeared. Nineteen days later, despite continuance of medication, Ms. A relapsed into an agitated depression, and the abnormal movements reappeared. Upward adjustment of her medications to 25-50 mg/day of imipramine and 40 mg/day of acetophenazine was followed 1 week later by the disappearance of both psychiatric and physical findings.

The staff regrets the errors.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.